BofA Securities Double Downgrades Sutro Biopharma (STRO) to Underperform
Tweet Send to a Friend
(Updated - March 14, 2025 6:22 AM EDT)
BofA Securities analyst Tazeen Ahmad downgraded Sutro Biopharma (NASDAQ: STRO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Tazeen Ahmad downgraded Sutro Biopharma (NASDAQ: STRO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
